Mark Frigerio

1.7k citations

22 papers · 1.2k indexed · h-index 15

Molecular Biology
Oncology top 10%
Organic Chemistry top 5%
Radiology, Nuclear Medicine and Imaging top 10%
Pharmacology top 10%

Co-authors: Marc Hummersone Karl J. Hale Soraya Manaviazar Andrew F. Kyle Keith Menear Xiaoling Cockcroft Laurent Rigoreau Nicholas C.K. Valerie
Topics: Synthetic Organic Chemistry Methods (6 papers)Cancer Treatment and Pharmacology (5 papers)DNA Repair Mechanisms (4 papers)
Cited by: Oncology Biotechnology Organic Chemistry
Journals: Cancer Research Scientific Reports Journal of Medicinal Chemistry
Partner nations: United Kingdom United States Australia

In The Last Decade

Mark Frigerio

22 papers receiving 1.1k citations

Peers

Countries citing papers authored by Mark Frigerio

Since Specialization

Citations

This map shows the geographic impact of Mark Frigerio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Frigerio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Frigerio more than expected).

Fields of papers citing papers by Mark Frigerio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Frigerio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Frigerio. The network helps show where Mark Frigerio may publish in the future.

Co-authorship network of co-authors of Mark Frigerio

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Frigerio. A scholar is included among the top collaborators of Mark Frigerio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Frigerio. Mark Frigerio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker 2021 ·Scientific Reports ·Marta Poblocka,(unknown),Victoria M. Smith,(unknown),Ana Sousa Manso,Mohammad Althubiti,Xiaobo Sheng,Andrew F. Kyle,Ruth Barber,Mark Frigerio,Salvador Macip	99
2	Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4 2019 ·mAbs ·(unknown),Uli Binder,William McDowell,Rita Tommasi,Mark Frigerio,William Darby,(unknown),(unknown),Matthias Macháček,Peter Lloyd,Arne Skerra,Michael Foley	22
3	The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates 2018 ·Current Topics in Medicinal Chemistry ·Mark Frigerio,Andrew F. Kyle	32
4	Antitumor imidazo[5,1-d]-1,2,3,5-tetrazines: compounds modified at the 3-position overcome resistance in human glioblastoma cell lines 2016 ·MedChemComm ·(unknown),Jihong Zhang,Marc Hummersone,Charles S. Matthews,Mark Frigerio,Tracey D. Bradshaw,Malcolm F. G. Stevens	16
5	1-Substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones Endowed with Dual DNA-PK/PI3-K Inhibitory Activity 2013 ·Journal of Medicinal Chemistry ·Céline Cano,(unknown),Chris Bailey,Julia Bárdos,Nicola J. Curtin,Mark Frigerio,Bernard T. Golding,Ian R. Hardcastle,Marc Hummersone,Keith Menear,David R. Newell,Caroline J. Richardson,(unknown),Graeme C.M. Smith,Pia Thömmes,Attilla Ting,Roger J. Griffin	42
6	On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts 2013 ·Journal of Experimental & Clinical Cancer Research ·Sara Iachettini,Malcolm F. G. Stevens,Mark Frigerio,Marc Hummersone,Ian Hutchinson,Thomas P. Garner,Mark S. Searle,David W. Wilson,Manoj Munde,Rupesh Nanjunda,Carmen D’Angelo,Pasquale Zizza,Angela Rizzo,Chiara Cingolani,Federica de Cicco,Manuela Porru,Maurizio D’Incalci,Carlo Leonetti,Annamaria Biroccio,Erica Salvati	26
7	DNA-Dependent Protein Kinase (DNA-PK) Inhibitors. Synthesis and Biological Activity of Quinolin-4-one and Pyridopyrimidin-4-one Surrogates for the Chromen-4-one Chemotype 2010 ·Journal of Medicinal Chemistry ·Céline Cano,Olivier Barbeau,C. L. Bailey,Xiaoling Cockcroft,Nicola J. Curtin,(unknown),Mark Frigerio,Bernard T. Golding,Ian R. Hardcastle,Marc Hummersone,Charlotte Knights,Keith Menear,David R. Newell,Caroline J. Richardson,Graeme C. M. Smith,(unknown),Roger J. Griffin	35
8	Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion 2009 ·Molecular Cancer Therapeutics ·Sarah E. Golding,Elizabeth Rosenberg,Nicholas C.K. Valerie,Isa M. Hussaini,Mark Frigerio,Xiaoling Cockcroft,(unknown),Marc Hummersone,Laurent Rigoreau,Keith Menear,Mark J. O’Connor,Lawrence F. Povirk,Timothy Van Meter,Kristoffer Valerie	285
9	Identification of potent water-soluble DNA-dependent protein kinase (DNA-PK) inhibitors using a small-molecule library approach [abstract] 2008 ·Cancer Research ·(unknown),Mark R. Albertella,Céline Cano,Nicola J. Curtin,Mark Frigerio,Bernard T. Golding,(unknown),Ian R. Hardcastle,Marc Hummersone,Keith Menear,David R. Newell,(unknown),Caroline J. Richardson,Laurent Rigoreau,(unknown),Graeme C.M. Smith,Roger J. Griffin	3
10	8-Biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) 2008 ·Bioorganic & Medicinal Chemistry Letters ·Marine Desage‐El Murr,Céline Cano,Bernard T. Golding,Ian R. Hardcastle,(unknown),Mark Frigerio,Nicola J. Curtin,Keith Menear,Caroline J. Richardson,Graeme C.M. Smith,Roger J. Griffin	18
11	Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure−Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase 2007 ·Journal of Medicinal Chemistry ·Jonathan J. Hollick,Laurent Rigoreau,Céline Cano,Xiaoling Cockcroft,Nicola J. Curtin,Mark Frigerio,Bernard T. Golding,(unknown),Ian R. Hardcastle,Ian Hickson,Marc Hummersone,Keith Menear,Niall M.B. Martin,Ian Matthews,David R. Newell,(unknown),Caroline J. Richardson,Graeme C.M. Smith,Roger J. Griffin	61
12	Enantioselective Formal Total Synthesis of the Antitumor Macrolide Bryostatin 7 2006 ·Organic Letters ·Soraya Manaviazar,Mark Frigerio,Gurpreet Singh Bhatia,Marc Hummersone,Abil E. Aliev,Karl J. Hale	66
13	Synthesis of a Simplified Bryostatin C-Ring Analogue That Binds to the CRD2 of Human PKC-α and Construction of a Novel BC-Analogue by an Unusual Julia Olefination Process 2003 ·Organic Letters ·Karl J. Hale,Mark Frigerio,Soraya Manaviazar,Marc Hummersone,Ian J. FILLINGHAM,(unknown),Christian Damblon,Andreas Gescher,Gordon C. K. Roberts	13
14	The chemistry and biology of the bryostatin antitumour macrolides 2002 ·Natural Product Reports ·Karl J. Hale,Marc Hummersone,Soraya Manaviazar,Mark Frigerio	149
15	The Chemistry and Biology of the Bryostatin Antitumor Macrolides 2002 ·ChemInform ·Karl J. Hale,Marc Hummersone,Soraya Manaviazar,Mark Frigerio	1
16	A Biosynthetic Proposal for Ring Formation in the Antitumor Agent Halichomycin. Asymmetric Synthesis of the AB-Carbon Backbone of Halichomycin 2002 ·Organic Letters ·Karl J. Hale,(unknown),(unknown),Mark Frigerio,Jonathan W. Steed,(unknown)	9
17	A Short Synthetic Pathway to a Fully-Functionalized Southern Hemisphere of the Antitumor Macrolide Bryostatin 1 2001 ·Organic Letters ·Karl J. Hale,Mark Frigerio,Soraya Manaviazar	16
18	Synthetic studies on the A83586C and bryostatin antitumor macrolides and the monamycin antibiotics 2000 ·Pure and Applied Chemistry ·Karl J. Hale,Marc Hummersone,Jiaqiang Cai,Soraya Manaviazar,Gurpreet Singh Bhatia,(unknown),Mark Frigerio,(unknown),(unknown),(unknown),(unknown)	11
19	Total synthesis of homochiral 3-deoxy-3-fluoromuscarines. 1990 ·Gazzetta chimica italiana ·(unknown),Mark Frigerio,Giuseppe Resnati,Fiorenza Viani,Alberto Arnone	11
20	Tiamdipines: A new class of Ca++-antagonists 1988 ·Pharmacological Research Communications ·C. Gandolfi,Mark Frigerio,(unknown),Andrea Zaliani,Alice Passoni,(unknown),(unknown),O. Tofanetti	3

About Mark Frigerio

Mark Frigerio is a scholar working on Toxicology, Oncology and Organic Chemistry, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Synthetic Organic Chemistry Methods (6 papers), Cancer Treatment and Pharmacology (5 papers) and DNA Repair Mechanisms (4 papers). The work is most often cited by research in Oncology (428 citations), Biotechnology (120 citations) and Organic Chemistry (382 citations). Mark Frigerio has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Marc Hummersone, Karl J. Hale, Soraya Manaviazar, Andrew F. Kyle, Keith Menear, Xiaoling Cockcroft, Laurent Rigoreau, Nicholas C.K. Valerie, Lawrence F. Povirk and Sarah E. Golding. Their work appears in journals such as Cancer Research, Scientific Reports and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact